New psychoactive substances: a multidisciplinary review of challenges and their diverse character
Authors:
- 7 August 2025
- journal article
- review article
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 33 (2) , 1-16
Abstract
Background New psychoactive substances (NPS) pose a rapidly evolving public health challenge due to their diverse chemical structures and psychoactive effects, necessitating a comprehensive understanding of their classification, mechanisms of action, and detection. Objectives Recognizing critical gaps in the understanding and management of NPS, this review aimed to synthesize current liter-ature. Specifically, we sought to elucidate the evolving classifications of NPS, delineate their underlying molecular mechanisms of action to inform therapeutic strategies, and critically evaluate existing detection methodologies to ad-dress current analytical limitations, thereby providing an essential, integrated perspective on this rapidly changing landscape. Methods A narrative literature review was conducted to analyze NPS classification, molecular mechanisms, and detection techniques. Searches were performed across Web of Science, Scopus, PubMed, and Elsevier, using keywords such as “synthetic cathinones”, “designer drugs”, “new psychoactive substance(s)”, “detection of new psychoactive sub-stances” and “toxicology.” Inclusion criteria prioritized studies primarily focused on NPS with clearly defined com-pounds (e.g., UNODC, EMCDDA classifications) and published within the last four years. Eligible publications en-compassed in vivo and in vitro studies, original research, and various review types. Exclusion criteria involved liter-ature outside the specified timeframe and studies on established drugs of abuse or licit substances, unless a direct comparative analysis with NPS was presented. Results The review synthesized a classification framework for NPS, detailed the molecular mechanisms underlying their psychoactive effects, and summarized current detection methodologies. Furthermore, it underscored the significant health risks associated with NPS use, including addiction, psychological disturbances, organ toxicity, and fatal outcomes. Conclusion The continued emergence and proliferation of NPS necessitate ongoing research to fully characterize their specific effects and associated risks. This review provides a foundational synthesis of current knowledge, not only supporting the development of evi-dence-based interventions to mitigate their public health impact, but also serving as a catalyst for new research direc-tions aimed at a deeper understanding and more effective management of these evolving compounds. Graphical abstractKeywords
This publication has 83 references indexed in Scilit:
- Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration studyDrug Testing and Analysis, 2023
- Pharmacological profile, phase I metabolism, and excretion time profile of the new synthetic cathinone 3,4‐Pr‐PipVPDrug Testing and Analysis, 2023
- Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole bloodDrug Testing and Analysis, 2021
- Metabolism study and toxicological determination of mephtetramine in biological samples by liquid chromatography coupled with high‐resolution mass spectrometryDrug Testing and Analysis, 2021
- Designer drugs: mechanism of action and adverse effectsArchives of Toxicology, 2020
- LC‐MS/MS method for the quantification of new psychoactive substances and evaluation of their urinary detection in humans for doping control analysisDrug Testing and Analysis, 2020
- Bioanalytical Methods for New Psychoactive Substances2018
- Neuropharmacology of Synthetic Cathinones2018
- Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometryDrug Testing and Analysis, 2014
- Detectability of new psychoactive substances, ‘legal highs’, in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuseDrug Testing and Analysis, 2014